Korean Post-marketing Surveillance Ngenla® Pre-filled Pen Injection for the Treatment of Pediatric Patients With Growth Disturbance Due to Insufficient Secretion of Growth Hormone
Clinical trial NCT05509894 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05509894
- Sponsor
- Pfizer
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-06-20
- Primary completion
- 2026-09-23
- Enrollment
- 565
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.